dc.contributor.author | Weintraub, Y | en_US |
dc.contributor.author | Veit, LC | en_US |
dc.contributor.author | Hussey, S | en_US |
dc.contributor.author | Mitrova, K | en_US |
dc.contributor.author | Croft, NM | en_US |
dc.contributor.author | Kang, B | en_US |
dc.contributor.author | Granot, M | en_US |
dc.contributor.author | D'Arcangelo, G | en_US |
dc.contributor.author | Spencer, E | en_US |
dc.contributor.author | Kolho, KL | en_US |
dc.contributor.author | Yeh, PJ | en_US |
dc.contributor.author | Sladek, M | en_US |
dc.contributor.author | Scarallo, L | en_US |
dc.contributor.author | Pérez, LP | en_US |
dc.contributor.author | Afzal, N | en_US |
dc.contributor.author | de Laffolie, J | en_US |
dc.contributor.author | Miele, E | en_US |
dc.contributor.author | Bramuzzo, M | en_US |
dc.contributor.author | Olén, O | en_US |
dc.contributor.author | Russell, R | en_US |
dc.contributor.author | Rohani, P | en_US |
dc.contributor.author | Tzivinikos, C | en_US |
dc.contributor.author | Urlep, D | en_US |
dc.contributor.author | van Rheenen, P | en_US |
dc.contributor.author | de Ridder, L | en_US |
dc.contributor.author | Yogev, D | en_US |
dc.contributor.author | Schneider, AM | en_US |
dc.contributor.author | Cohen, S | en_US |
dc.contributor.author | Romero, RG | en_US |
dc.contributor.author | Dipasquale, V | en_US |
dc.contributor.author | Uhlig, H | en_US |
dc.contributor.author | S., DS | en_US |
dc.date.accessioned | 2024-07-31T11:34:38Z | |
dc.date.issued | 2024-01-24 | en_US |
dc.identifier.issn | 1197-4982 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/98501 | |
dc.format.extent | i1114 - i1115 | en_US |
dc.publisher | Oxford University Press (OUP) | en_US |
dc.relation.ispartof | Journal of Crohn's and Colitis | en_US |
dc.subject | Digestive Diseases | en_US |
dc.subject | Clinical Research | en_US |
dc.subject | Inflammatory Bowel Disease | en_US |
dc.subject | Clinical Trials and Supportive Activities | en_US |
dc.subject | Autoimmune Disease | en_US |
dc.subject | Pediatric | en_US |
dc.subject | Crohn's Disease | en_US |
dc.subject | 5.1 Pharmaceuticals | en_US |
dc.subject | 6.1 Pharmaceuticals | en_US |
dc.subject | Oral and gastrointestinal | en_US |
dc.title | P570 Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/ecco-jcc/jjad212.0700 | en_US |
pubs.issue | Supplement_1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 18 | en_US |